Divi's Laboratories Limited vs Rainbow Childrens Medicare Limited

A side-by-side comparison of Divi's Laboratories Limited (DIVISLAB) and Rainbow Childrens Medicare Limited (RAINBOW) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.

The verdict

On the numbers, Divi's Laboratories Limited leads DIVISLAB vs RAINBOW on 10 of 14 metrics. See the breakdown below — the right pick still depends on your goals (value vs growth, risk appetite).

  • Valuation22
  • Profitability31
  • Growth11
  • Size & financial health40
ValueReturnsMarginGrowthScaleLow debt

Each axis shows this group's split of that metric, scaled so the leader sits at the edge. Relative to each other, not an absolute score.

Valuation

Even

How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.

94.52
P/E ratio
45.64
14.90
P/B ratio
8.89
0.32%
Dividend yield
0.24%
₹96.75
EPS
₹27.41

Profitability

DIVISLAB takes 3/4

How efficiently each company turns capital and sales into profit. Higher is better.

15.32%
Return on equity
16.89%
20.35%
Return on capital
17.17%
32.59%
EBITDA margin
31.95%
24.32%
Net margin
16.53%

Growth

Even

Three-year compounded growth. Faster-growing businesses can justify a higher valuation.

10.78%
Revenue CAGR (3Y)
13.22%
12.09%
Profit CAGR (3Y)
9.85%

Size & financial health

DIVISLAB takes 4/4

Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.

₹2.45L Cr
Market cap
₹12,662 Cr
₹10,560 Cr
Revenue
₹1,703 Cr
₹2,568 Cr
Net profit
₹282 Cr
0.00
Debt / equity
0.54
Divi's Laboratories Limited
  • + ["Company has been maintaining a healthy dividend payout of 31.0%", "Company is almost debt free."]
  • − ["Stock is trading at 14.48 times its book value", "The company has delivered a poor sales growth of 8.7% over past five years."]
Rainbow Childrens Medicare Limited
  • + ["Company has delivered good profit growth of 47.7% CAGR over last 5 years", "Company has delivered good sales growth of 21.2% CAGR over last 5 years"]
  • − ["Stock is trading at 7.70 times its book value"]
Divi's Laboratories Limited full analysis Rainbow Childrens Medicare Limited full analysis

This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.